Global Oncology Information System Market Size study & Forecast, by Products & Services (Solutions, Professional Services), by Application (Medical Oncology, Surgical Oncology), by End-use and Regional Forecasts 2025-2035

The Global Oncology Information System Market, valued at approximately USD 2.9 billion in 2024, is projected to expand at a CAGR of 8.10% from 2025 to 2035. These systems, designed to streamline and integrate the complex landscape of cancer care, provide a centralized platform for managing patient data, treatment planning, and workflow optimization across multidisciplinary teams. Oncology information systems (OIS) have become indispensable in modern cancer treatment centers, bridging the gap between clinical practice and digital healthcare infrastructure. As cancer incidence rates continue to rise globally, coupled with the growing emphasis on precision medicine and value-based care, the adoption of OIS is poised for rapid acceleration. The increasing demand for interoperable platforms, capable of supporting advanced imaging, radiation therapy, chemotherapy management, and outcome tracking, further underscores their critical role in improving both patient experiences and operational efficiency.

The market’s growth is propelled by a convergence of factors, including rising cancer prevalence, continuous advancements in oncology diagnostics and therapeutics, and the expanding integration of artificial intelligence in clinical decision-making. Healthcare providers are recognizing the value of oncology information systems not only for enhancing clinical outcomes but also for facilitating regulatory compliance, data analytics, and clinical research. According to the International Agency for Research on Cancer (IARC), global cancer cases are expected to reach over 28 million by 2040, highlighting an urgent need for scalable and intelligent OIS solutions. Moreover, the rising penetration of cloud-based platforms, real-time analytics, and predictive modeling tools has significantly expanded the capabilities of these systems, empowering oncologists to deliver more personalized, coordinated, and efficient care. However, challenges such as high deployment costs, data privacy concerns, and the need for robust interoperability with legacy systems may temper adoption rates, particularly in emerging markets.

North America currently leads the market, driven by a mature healthcare IT infrastructure, high per-capita healthcare spending, and strong adoption of electronic health records (EHRs) across oncology care networks. The presence of leading solution providers, combined with favorable reimbursement policies and growing investment in cancer research, strengthens the region’s dominance. Europe follows closely, supported by rising healthcare digitization initiatives, well-established cancer registries, and increasing emphasis on multidisciplinary cancer care. The Asia Pacific region is forecasted to witness the fastest growth over the coming decade, fueled by surging cancer incidence, expanding healthcare access, government-backed cancer control programs, and rapid advancements in hospital IT infrastructure in countries like China, India, and Japan. Meanwhile, Latin America and the Middle East & Africa are gradually adopting oncology information systems as awareness of their clinical and operational benefits spreads, supported by targeted investments in healthcare modernization projects.

Major market player included in this report are:
• Elekta AB
• Varian Medical Systems, Inc.
• Cerner Corporation
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• McKesson Corporation
• RaySearch Laboratories AB
• Accuray Incorporated
• Flatiron Health, Inc.
• ViewRay Technologies, Inc.
• IBM Watson Health
• Meditech
• Epic Systems Corporation
• CureMD Healthcare
• Optum, Inc.

Global Oncology Information System Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Products & Services:
• Solutions
• Professional Services

By Application:
• Medical Oncology
• Surgical Oncology

By End-use:
• Hospitals & Diagnostic Imaging Centers
• Research Centers
• Cancer Care Centers
• Others

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more